Industry
Pharmaceuticals
Developers of branded and generic drugs. Value creation rests on R&D pipelines, patent lifecycles, regulatory approvals and pricing power versus payers.
Total Companies
1.224
1.141 stocks
| Empresa | Último precio | Cambio de precio | Capitalización bursátil | ||
|---|---|---|---|---|---|
|
|
|
Eli Lilly and Co
LLY
|
$1.164,56 |
-2%
|
$1,10 T |
|
|
|
Johnson & Johnson
JNJ
|
$256,72 |
-0,7%
|
$618,67 B |
|
|
|
Merck & Co Inc
MRK
|
$141,99 |
-0,6%
|
$350,69 B |
|
|
|
Novartis AG
NOVN
|
CHf117,44 |
-2,1%
|
$267,87 B |
|
|
|
AstraZeneca PLC
AZN
|
11.892 |
-2,4%
|
$243,77 B |
|
|
|
Nuvo Pharmaceuticals Inc
MRV
|
CA$45,99 |
-0,9%
|
$235,93 B |
|
|
|
Novo Nordisk A/S
NOVO B
|
kr250,25 |
-1,4%
|
$165,70 B |
|
|
|
Pfizer Inc
PFE
|
$27,83 |
-0,6%
|
$158,62 B |
|
|
|
Bristol-Myers Squibb Co
BMY
|
$59,915 |
+0,4%
|
$122,35 B |
1.136 resultados ocultos
Crea una cuenta gratuita para desbloquear acceso adicional y mejora para ver todos los resultados
Crear cuenta gratuita